BMY Operating Cash Flow (Statement)

Bristol Myers Squibb · Operating Cash Flow (Statement)

BMY logo

BMY Operating Cash Flow (Statement)

Latest reported$3.39B
BMY Quarterly Cash from Operations ($383.00M → $3.39B)
High-resolution chart · PNG

BMY operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
3,393,000,000
1,104,000,000
1,974,000,000
6,311,000,000
3,917,000,000
1,954,000,000
4,439,000,000
5,591,000,000
2,326,000,000
2,834,000,000
4,252,000,000
4,751,000,000
1,887,000,000
2,970,000,000
3,306,000,000
3,687,000,000
2,261,000,000
3,812,000,000
4,057,000,000
5,266,000,000
3,060,000,000
3,824,000,000
3,670,000,000
2,267,000,000
4,493,000,000
3,937,000,000
2,038,000,000
2,556,000,000
2,083,000,000
1,390,000,000
2,429,000,000
1,279,000,000
1,057,000,000
1,175,000,000
1,117,000,000
1,713,000,000
1,584,000,000
861,000,000
1,428,000,000
1,404,000,000
439,000,000
-228,000,000
611,000,000
524,000,000
71,000,000
626,000,000
572,000,000
903,000,000
1,056,000,000
617,000,000
1,410,000,000
1,053,000,000
1,510,000,000
-428,000,000
836,000,000
4,584,000,000
1,134,000,000
387,000,000
1,568,000,000
1,698,000,000
1,093,000,000
481,000,000
1,595,000,000
1,383,000,000
1,049,000,000
464,000,000
1,344,000,000
1,473,000,000
796,000,000
452,000,000
366,000,000
1,452,000,000
1,114,000,000
775,000,000
630,000,000
697,000,000
1,061,000,000
765,000,000
211,000,000
944,000,000
845,000,000
83,000,000
325,000,000
760,000,000
-4,000,000
783,000,000
683,000,000
581,000,000
831,000,000
1,081,000,000
1,252,000,000
951,000,000
1,150,000,000
160,000,000
693,000,000
937,000,000
406,000,000
-1,086,000,000
1,966,000,000
1,053,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.